Canopy Growth Corporation Share Price

Equities

WEED

CA1380357048

Pharmaceuticals

Market Closed - Toronto S.E. 21:18:04 17/05/2024 BST 5-day change 1st Jan Change
14.81 CAD -1.07% Intraday chart for Canopy Growth Corporation +19.82% +119.08%

Financials

Sales 2024 * 321M 236M 18.56B Sales 2025 * 303M 222M 17.51B Capitalization 1.25B 915M 72.11B
Net income 2024 * -491M -360M -28.41B Net income 2025 * -121M -88.84M -7B EV / Sales 2024 * 5.22 x
Net Debt 2024 * 427M 314M 24.7B Net Debt 2025 * 403M 296M 23.31B EV / Sales 2025 * 5.45 x
P/E ratio 2024 *
-2.53 x
P/E ratio 2025 *
-12 x
Employees 1,621
Yield 2024 *
-
Yield 2025 *
-
Free-Float 82.87%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.07%
1 week+19.82%
Current month-27.58%
1 month+66.22%
3 months+187.57%
6 months+92.34%
Current year+119.08%
More quotes
1 week
12.28
Extreme 12.28
16.27
1 month
10.32
Extreme 10.32
20.50
Current year
3.74
Extreme 3.74
20.50
1 year
3.74
Extreme 3.74
26.00
3 years
3.74
Extreme 3.74
326.00
5 years
3.74
Extreme 3.74
716.00
10 years
3.74
Extreme 3.74
766.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 31/10/18
Director of Finance/CFO 52 01/12/19
Investor Relations Contact - 31/12/15
Members of the board TitleAgeSince
Chief Executive Officer 60 31/10/18
Chairman 69 30/03/20
Director/Board Member 67 30/03/20
More insiders
Date Price Change Volume
17/05/24 14.81 -1.07% 4,071,279
16/05/24 14.97 +11.22% 9,117,360
15/05/24 13.46 +1.36% 2,801,739
14/05/24 13.28 +3.51% 4,339,303
13/05/24 12.83 +3.80% 2,817,064

Delayed Quote Toronto S.E., May 17, 2024 at 09:18 pm

More quotes
Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
14
Last Close Price
14.81 CAD
Average target price
7.808 CAD
Spread / Average Target
-47.28%
Consensus